2 Results Sort by:
HDAC Inhibitors for Managing Vascular Conditions and Diabetic Peripheral Neuropathies
Application Treatment of diabetic neuropathy using epigenetic modulators, histone deacetylase inhibitors (HDACis), to ameliorate or prevent vascular conditions and neuropathic pains by nerve damages. Key Benefits Reverses or protects against diabetes-induced nerve damages by direct injection of HDACi. Relatively low regulatory risk because many...
Published: 4/23/2024       Contributor(s): Young-Sup Yoon, Ji Woong (Jay) Han, Hyunsuk Shim
Guide to Goals (G2G): Application for Type 1 Diabetes Management in Children
Application Web-based application for both self and clinical assessment and management of pediatric type 1 diabetes population. Key Benefits Specific for pediatric type 1 diabetes population. Patient involvement at point-of-care encourages patient-directed, goal-driven therapy. Provides simple, user friendly interface based on American Diabetes...
Published: 4/23/2024       Contributor(s): Andrew Muir, Prabhu Shankar, Michael Owens, Leanne West, Gregory Bishop, Yevgeniy Agalov